Avalyn Pharma Inc.
- Last sale
- Nov 12, 2026 · -3.12%
- Market cap
- $1.36B
- 44.52M shares
- Filings
- 67
—
—
—Q3 2026
—Q3 2026
—Q3 2026derived
—Q3 2026
—Q3 2026+118.4% FY25 yoy
- $1.36B
- —
- —
- 3.7×
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Total Interest and Dividend Income
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Avalyn Pharma Inc. is the 126th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ANABAnaptysbio, Inc$234.6M157.0%5.6%$1.4BOCULOcular Therapeutix, Inc$52.0M18.5%511.9%$1.4BAAPGAscentage Pharma Group International———$1.4BMLYSMineralys Therapeutics, Inc.———$1.4BDMRADamora Therapeutics, Inc.———$1.4B
AVLNAvalyn Pharma Inc. (this company)———$1.4B
INVAInnoviva, Inc.$411.3M14.7%65.9%$1.3BMNKDMannkind Corp$349.0M22.2%1.7%$1.3BKARDKardigan, Inc.———$1.3BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Avalyn Pharma Inc. · CIK 1540171 · Engraved from SEC EDGAR